Works matching IS 02770008 AND DT 2016 AND VI 36 AND IP 10
Results: 11
Management of Dabigatran-Associated Bleeding with Two Doses of Idarucizumab Plus Hemodialysis.
- Published in:
- Pharmacotherapy, 2016, v. 36, n. 10, p. e160, doi. 10.1002/phar.1830
- By:
- Publication type:
- Article
Community Pharmacists Assisting in Total Cardiovascular Health (CPATCH): A Cluster-Randomized, Controlled Trial Testing a Focused Adherence Strategy Involving Community Pharmacies.
- Published in:
- Pharmacotherapy, 2016, v. 36, n. 10, p. 1055, doi. 10.1002/phar.1831
- By:
- Publication type:
- Article
A Quantitative Analysis of FDA Adverse Event Reports with Oral Bisphosphonates and Clostridium difficile.
- Published in:
- Pharmacotherapy, 2016, v. 36, n. 10, p. 1095, doi. 10.1002/phar.1832
- By:
- Publication type:
- Article
Value of a Community-Based Medication Management Review Service in Jordan: A Prospective Randomized Controlled Study.
- Published in:
- Pharmacotherapy, 2016, v. 36, n. 10, p. 1075, doi. 10.1002/phar.1833
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacotherapy, 2016, v. 36, n. 10, p. 1043, doi. 10.1002/phar.1838
- Publication type:
- Article
Effect of Linezolid on Hematologic Recovery in Newly Diagnosed Acute Myeloid Leukemia Patients Following Induction Chemotherapy.
- Published in:
- Pharmacotherapy, 2016, v. 36, n. 10, p. 1087, doi. 10.1002/phar.1824
- By:
- Publication type:
- Article
Successful Use of Ceftolozane-Tazobactam to Treat a Pulmonary Exacerbation of Cystic Fibrosis Caused by Multidrug-Resistant Pseudomonas aeruginosa.
- Published in:
- Pharmacotherapy, 2016, v. 36, n. 10, p. e154, doi. 10.1002/phar.1825
- By:
- Publication type:
- Article
Identifying Subsequent Therapies in Patients with Advanced Non-Small Cell Lung Cancer and Factors Associated with Overall Survival.
- Published in:
- Pharmacotherapy, 2016, v. 36, n. 10, p. 1065, doi. 10.1002/phar.1826
- By:
- Publication type:
- Article
Comparison of Fresh-Frozen Plasma, Four-Factor Prothrombin Complex Concentrates, and Recombinant Factor VIIa to Facilitate Procedures in Critically Ill Patients with Coagulopathy from Liver Disease: A Retrospective Cohort Study.
- Published in:
- Pharmacotherapy, 2016, v. 36, n. 10, p. 1047, doi. 10.1002/phar.1827
- By:
- Publication type:
- Article
Rivaroxaban versus Heparin Bridging to Warfarin Therapy: Impact on Hospital Length of Stay and Treatment Costs for Low-Risk Patients with Pulmonary Embolism.
- Published in:
- Pharmacotherapy, 2016, v. 36, n. 10, p. 1109, doi. 10.1002/phar.1828
- By:
- Publication type:
- Article
An Optimized Voriconazole Dosing Strategy to Achieve Therapeutic Serum Concentrations in Children Younger than 2 Years Old.
- Published in:
- Pharmacotherapy, 2016, v. 36, n. 10, p. 1102, doi. 10.1002/phar.1829
- By:
- Publication type:
- Article